Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I’M WOMAN)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I’M WOMAN) ; volume:24 ; number:1 ; day:3 ; month:12 ; year:2023 ; pages:1-17 ; date:12.2023
Trials ; 24, Heft 1 (3.12.2023), 1-17, 12.2023
- Creator
-
Brenner, Amy
Shakur-Still, Haleema
Chaudhri, Rizwana
Muganyizi, Projestine
Olayemi, Oladapo
Arribas, Monica
Kayani, Aasia
Javid, Kiran
Bello, Adenike
Roberts, Ian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-023-07687-1
- URN
-
urn:nbn:de:101:1-2024022111450901437837
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Brenner, Amy
- Shakur-Still, Haleema
- Chaudhri, Rizwana
- Muganyizi, Projestine
- Olayemi, Oladapo
- Arribas, Monica
- Kayani, Aasia
- Javid, Kiran
- Bello, Adenike
- Roberts, Ian
- SpringerLink (Online service)
Other Objects (12)
High-dose tranexamic acid reduces blood loss in postpartum haemorrhage
Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial
Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial
Intramuscular uptake of tranexamic acid during haemorrhagic shock in a swine model
Trends and outcomes of postpartum haemorrhage, 2003-2011
Prevention of postpartum haemorrhage: a distributional approach for analysis
The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
Intramuscular injection, intravenous infusion, and intravenous bolus of oxytocin in the third stage of labor for prevention of postpartum hemorrhage: a three-arm randomized control trial
The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial
Assessment the role of tranexamic acid in prevention of postpartum hemorrhage
Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]
Exploring trends of severe postpartum haemorrhage: a hospital-based study
High-dose tranexamic acid reduces blood loss in postpartum haemorrhage
Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial
Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial
Intramuscular uptake of tranexamic acid during haemorrhagic shock in a swine model
Trends and outcomes of postpartum haemorrhage, 2003-2011
Prevention of postpartum haemorrhage: a distributional approach for analysis
The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
Intramuscular injection, intravenous infusion, and intravenous bolus of oxytocin in the third stage of labor for prevention of postpartum hemorrhage: a three-arm randomized control trial
The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial
Assessment the role of tranexamic acid in prevention of postpartum hemorrhage
Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]
Exploring trends of severe postpartum haemorrhage: a hospital-based study
High-dose tranexamic acid reduces blood loss in postpartum haemorrhage
Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial
Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial
Intramuscular uptake of tranexamic acid during haemorrhagic shock in a swine model
Trends and outcomes of postpartum haemorrhage, 2003-2011
Prevention of postpartum haemorrhage: a distributional approach for analysis
The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
Intramuscular injection, intravenous infusion, and intravenous bolus of oxytocin in the third stage of labor for prevention of postpartum hemorrhage: a three-arm randomized control trial
The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial
Assessment the role of tranexamic acid in prevention of postpartum hemorrhage
Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]